Íslenska
Search
My pages
Main menu
Close
  • Medicinal products
  • Development
  • Medical Devices
  • Regulated entities
  • Pricing and Reimbursement
  • Published Material
  • IMA
  • Medicinal products
    • About Medicinal products
    • Importation by Individuals of Medicinal Products for Personal Use
    • Marketing Authorisations
      • Conditions for Marketing
      • Electronic Applications
      • Package labelling and leaflets
      • Other Registrations/Authorisations
      • RMS Requests
      • Text Processing
      • Withdrawals
      • Zero Day Procedure
    • Pharmacovigilance
      • Report an Adverse Drug Reaction
    • Quality Standards
    • Reported Medicine Shortage – Overview
    • Safety Features of Medicinal Products
  • Development
    • About Development
    • Clinical Trials
      • Application for a Clinical Trial
      • Clinical Trials Information System (CTIS)
      • Substantial Amendments
      • Notifications and Reports
      • SUSAR Reporting
      • Approvals for Clinical Trial Applications
      • CTFG / VHP
    • Scientific Advice
  • Medical Devices
    • About Medical Devices
    • Instructions for use
    • Use and vigilance of Medical Devices
    • Registration of distributors
    • CE Marking
    • Incident Report for Medical Devices
  • Regulated entities
    • About Regulated entities
    • Manufacturers
    • Medical Centers
    • Narcotic Drugs and Other Controlled Substances
      • Controlled Substances
      • Narcotics
    • Other Regulated Entities
    • Pharmacies
      • Pharmacy License
    • Wholesalers and Distributors
      • Licenses for Import and Wholesale Distribution of Medicinal Products
  • Pricing and Reimbursement
    • About Pricing and reimbursement
    • Icelandic Medicine Price Catalogue
    • The Exchange Rate of the Icelandic Price Catalogue
  • Published Material
    • About Published Material
    • Annual Reports
    • FAQ
    • Forms
    • Guidelines
    • Lists
    • News
  • IMA
    • About IMA
    • Roles and Organization
    • Strategy
    • Employees
    • Fees
    • Laws and Regulations

Type your search and press enter

Type what you want to find

Greinasafn

December 16, 2021

10. What is EU Clinical Trials Register?

December 16, 2021

09. When a sponsor reports a serious adverse reaction into the EudraVigilance database with IMA and EMA as recipients, does the report appear twice?

December 16, 2021

08. What is the fee for substantial amendment assessment?

December 16, 2021

07. What is the fee for a clinical trial assessment?

December 16, 2021

06. Is it sufficient to submit one application for a multi-centre trial in Iceland?

December 16, 2021

05. Who can import an investigational medicinal product?

December 16, 2021

04. What is VHP?

December 16, 2021

03. How do I create a EudraCT number?

December 16, 2021

02. Is your trial a non-interventional study?

December 16, 2021

01. Is your trial a clinical trial of medicinal products?

Want to get the latest news from us?
 

Nánar um persónuverndarstefnu okkar.

  • Facebook
  • Instagram
  • Soundcloud
  • Youtube
  • Contact us
  • Eyðublöð
  • Lög og reglugerðir
  • Lagalegur fyrirvari
  • Fyrir fjölmiðla
  • Persónuverndar­stefna
Lyfjastofnun Gæði - Traust - Þjónusta Vínlandsleið 14 113 Reykjavík S: +354 520-2100
Opening hours Open every weekday in between 9:00 - 15:00 Opnunartímar þjónustuvers Open every weekday in between 9:00 - 15:00
Lyfjastofnun fékk Jafnlaunavottun fyrir árið 2019-2022